Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases.
Yaqi YangDongxia MaNan HuangWenjing LiQing JiangYin WangXiaolong WangLin YangRong-Fei ZhuPublished in: Italian journal of pediatrics (2021)
HDM subcutaneous immunotherapy is considered to be safe in preschool children with respiratory allergic diseases. Higher BMI and HDM sIgE level in children are risk factors for developing LRs. The incidence of SRs and the rate of severe SRs are low in preschool children.